|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Behrens, Frank; Rech, Jürgen; Thaci, Diamant; Zinke, Silke; Rothnie, Kieran J.; (Oefner) Daamen, Carolin und Leipe, Jan
(2021):
High rates of therapeutic changes in patients with psoriatic arthritis receiving treatment with disease-modifying antirheumatic drugs: A cross-sectional study.
In: Modern Rheumatology, Bd. 32, Nr. 1: S. 87-95
Ghoreschi, Kamran; Augustin, Matthias; Baraliakos, Xenofon; Kroenke, Gerhard; Schneider, Matthias; Schreiber, Stefan; Schulze-Koops, Hendrik; Zeissig, Sebastian und Thaci, Diamant
(2021):
TYK2 inhibition and its potential in the treatment of chronic inflammatory immune diseases.
In: Journal der Deutschen Dermatologischen Gesellschaft, Bd. 19, Nr. 10: S. 1409-1420
Lebwohl, Mark; Kircik, Leon; Lacour, Jean-Philippe; Liljedahl, Monika; Lynde, Charles; Morch, Marie Holst; Papp, Kim A.; Perrot, Jean-Luc; Gold, Linda Stein; Takhar, Amrit; Thaci, Diamant; Warren, Richard B. und Wollenberg, Andreas
(2021):
Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).
In: Journal of the American Academy of Dermatology, Bd. 84, Nr. 5: S. 1269-1277
Paller, Amy S.; Wollenberg, Andreas; Siegfried, Elaine; Thaci, Diamant; Cork, Michael J.; Arkwright, Peter D.; Gooderham, Melinda; Sun, Xian; O'Malley, John T.; Khokhar, Faisal A.; Vakil, Jignesh; Bansal, Ashish; Rosner, Karli; Shumel, Brad und Levit, Noah A.
(2021):
Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.
In: Pediatric Drugs, Bd. 23, Nr. 5: S. 515-527
Simpson, Eric L.; Paller, Amy S.; Siegfried, Elaine C.; Thaci, Diamant; Wollenberg, Andreas; Cork, Michael J.; Marcoux, Danielle; Huang, Rui; Chen, Zhen; Rossi, Ana B.; Shumel, Brad; Sierka, Debra und Bansal, Ashish
(2021):
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older.
In: Dermatology and Therapy, Bd. 11, Nr. 5: S. 1643-1656
Wasel, Norman; Thaci, Diamant; French, Lars E.; Conrad, Curdin; Dutronc, Yves; Gallo, Gaia; Berggren, Lovisa und Lacour, Jean-Philippe
(2020):
Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S).
In: Dermatology and Therapy, Bd. 10, Nr. 4: S. 663-670
Paller, Amy S.; Siegfried, Elaine C.; Thaci, Diamant; Wollenberg, Andreas; Cork, Michael J.; Arkwright, Peter D.; Gooderham, Melinda; Beck, Lisa A.; Boguniewicz, Mark; Sher, Lawrence; Weisman, Jamie; O'Malley, John T.; Patel, Naimish; Hardin, Megan; Graham, Neil M. H.; Ruddy, Marcella; Sun, Xian; Davis, John D.; Kamal, Mohamed A.; Khokhar, Faisal A.; Weinreich, David M.; Yancopoulos, George D.; Beazley, Bethany; Bansal, Ashish und Shumel, Brad
(2020):
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
In: Journal of the American Academy of Dermatology, Bd. 83, Nr. 5: S. 1282-1293